Home » Topics » Regulatory » Patents

Patents
RSS

Shanghai Haiyan Pharmaceutical Technology and Yangtze River Pharmaceutical disclose EGFR inhibitors

April 19, 2016

Lead Discovery Center and Merck KGaA report proteasome inhibitors

April 19, 2016

A*STAR reports antimicrobial imidazolium compounds

April 18, 2016

Trinity College Dublin divulges compounds for multiple sclerosis

April 18, 2016

Flatley Discovery Lab patents CFTR channel correctors

April 18, 2016

Proximagen reports development of SSAO inhibitors

April 18, 2016

Infinity Pharmaceuticals develops PI3Kgamma inhibitors

April 18, 2016

PI3K inhibitors revealed in XuanZhu Pharma patent

April 15, 2016

XuanZhu Pharma describes ALK and MCF3 inhibitors

April 15, 2016

Redx Pharma develops IDO1 and/or TDO2 inhibitors

April 15, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...